Jorimann L, Tschumi J, Zeeb M, Leemann C, et al. Absence of proviral HIV-1 evolution in early treated individuals with HIV switching to dolutegravir monotherapy during 48 weeks. J Infect Dis 2023 Jul 27:jiad292. doi: 10.1093.
PMID: 37498738